HL7 Clinical Import Demo:
15,075 Patients to Production
An end-to-end demonstration of Buffaly taking a real clinical archive, building and running its own HL7 C-CDA import pipeline, validating patient data at scale, and turning the result into a scored, payer-aware patient opportunity pipeline.
Execution Milestones
Clinical workflow1. A real patient-data archive was acquired locally
A shared clinical archive was downloaded into local staging and verified by path, size, hash, and timestamp.
This established chain-of-custody for a real healthcare data source before any import or transformation work began.
2. The archive was inspected safely before import
The gzip file was probed non-destructively and showed structured decompressed clinical content.
This confirmed the source contained meaningful patient-document payloads rather than an opaque binary artifact.
3. Local FairPath access was restored for clinical validation work
The local FairPath environment was repaired enough to open superadmin, although the route still returned HTTP 500.
The EMR-adjacent local environment became reachable for inspection and validation of imported healthcare data.
4. The effort shifted from file handling to clinical import capability
The work evolved into building a reusable HL7 C-CDA importer instead of stopping at manual file inspection.
This is the core EMR story: moving from archive access to reliable ingestion of structured clinical records.
5. The importer was designed around actual EMR data domains
The import path was built to extract patient demographics, ICD-10 conditions, RxNorm medications, insurance / payer information, and last-visit data.
These are the categories that make imported data operationally useful inside an EMR environment.
6. The workflow was captured as reusable capability
The HL7 C-CDA import flow was turned into a reusable Buffaly capability so the import path could be run again without rebuilding the process from scratch.
The healthcare import process became repeatable and discoverable, not dependent on one person remembering manual steps.
7. New code was added to parse real HL7 C-CDA content
New FairPath staging logic was added to parse CDA structures and map them into patient import rows.
The platform gained a true medical document ingestion capability rather than a generic file loader.
8. Standard clinical vocabularies were recognized during import
The importer was built to parse ICD-10 condition codes and RxNorm medication codes from the CDA documents.
The workflow handled standardized clinical semantics, not just free-text copying.
9. Insurance and payer information were included in the imported record set
Insurance and payer data were extracted from the source documents alongside patient and visit information.
For EMR and revenue-cycle stakeholders, imported data is far more useful when coverage data is preserved.
10. Last-visit information was derived from clinical encounters
The import flow derived visit recency from encounter and service effective times in the source content.
Visit recency drives outreach, filtering, and clinical relevance in downstream workflows.
11. Inactive-patient filtering was designed into the importer
The workflow included exclusion rules for inactive patients not seen in at least two years.
This shows the import was built around clinically meaningful hygiene rules, not indiscriminate bulk loading.
12. The importer succeeded at real healthcare-data scale
More than 15,000 XML documents were parsed and 15,075 patient records were imported.
This demonstrates EMR-scale execution rather than a toy proof-of-concept.
13. Only two records failed, and the failure was medically plausible
Two records failed because pre-1753 source dates caused SQL datetime lower-bound overflow.
This is a realistic legacy-clinical-data edge case and exactly the kind of thing an interoperability workflow must surface and handle.
14. Imported medical records landed in the operational FairPath model
The session documented landing counts in the operational patient-import structures with the correct organization mapping into the intended target.
The imported patient data was persisted into the intended operational structure, not merely parsed in memory.
15. The imported patient cohort matched the intended inactivity rules
Validation showed the imported set was consistent with the intended inactive-patient cutoff logic used for the run.
This increases confidence that the cohort reflects clinical/business criteria rather than uncontrolled bulk import.
16. The work moved from volume validation to patient-level clinical correctness
Specific patient records were reviewed for MRN correctness, condition capture across visits, medication capture with RxNorm, and insurance accuracy.
This is the trust-building phase EMR stakeholders care about most: not just whether it imported, but whether it imported correctly.
17. Downstream medical-field representation issues were identified
The session investigated why a new MRN was not appearing correctly and why multiple condition fields appeared downstream.
Correct ingestion alone is not enough in an EMR; the data must also be represented coherently for users and downstream logic.
18. Patient conditions were used to clinically qualify patients
After import, patient conditions were interpreted through ICD-10 codes and matched against specialty lookup logic to determine which patients were clinically relevant for targeted programs.
The workflow was no longer just storing diagnoses. It was using clinical history to identify which patients were appropriate candidates for specific care-management and remote-monitoring programs.
19. Insurance was normalized to support payer-aware qualification
Insurance and payer data were cleaned up and normalized so patients could be evaluated consistently by coverage and reimbursement context.
Clinical fit alone was not enough. Patients also needed payer alignment to become operationally viable for customer use.
20. Novitas policy research was incorporated into program eligibility
The workflow included research into Novitas payment policies for RPM, APCM, and CCM so qualification could reflect actual reimbursement rules rather than diagnosis presence alone.
This connected imported clinical data to real-world billing and care-program feasibility.
21. Program-specific scores were assigned to patients
Using imported diagnoses, specialty mapping, normalized insurance, and payer-policy logic, patients were assigned scores representing how strongly they matched the target programs.
The imported chart data became a ranked operational opportunity set instead of a static imported population.
22. The imported population was stratified into priority tiers
Patients were stratified so the strongest candidates rose to the top while weaker or incomplete candidates remained available for later review.
Not every patient was equally ready for action. The workflow created a clinically and operationally prioritized queue.
23. A production push path was attempted against the live environment
The session compiled and ran the live promotion workflow for the highest-priority cohort, then isolated the remaining blocker in that path.
This showed the workflow had progressed beyond local scoring into live-environment promotion work, while still preserving operational safety by surfacing the exact blocker instead of claiming a completed promotion.
24. The remaining patients stayed in local staging
Qualified-but-not-yet-promoted patients remained in the local staging database for continued refinement, validation, and future movement.
The workflow preserved a safe boundary: production received the best-ready cohort while staging remained the place for continued tuning and review.
25. The final result was a medically qualified, payer-aware production pipeline
The session ended with a functioning pipeline that started with clinical archive ingestion and progressed through diagnosis-based qualification, payer normalization, Novitas policy research, scoring, stratification, and partial production deployment with the remaining live-environment blocker clearly isolated.
For an EMR audience, the true outcome was not just data import. It was a prioritized, reimbursable, production-ready patient opportunity pipeline.